Besides their function in limiting blood loss and promoting wound healing, experimental
evidence has highlighted platelets as active players in all steps of tumorigenesis including …

Background Daily aspirin reduces the long-term risk of death due to cancer. However, the
short-term effect is less certain, especially in women, effects on cancer incidence are largely …

Importance Aspirin and cyclooxygenase 2 (COX-2) inhibitors have been associated with a
reduced risk of colorectal polyps and cancer in observational and randomized studies. The …

Considerable evidence supports the effectiveness of aspirin for chemoprevention of
colorectal cancer (CRC) in addition to its well-established benefits in the prevention of …

Background Low-dose aspirin has been shown to reduce the incidence of cancer, but its
role in the treatment of cancer is uncertain. Objectives We conducted a systematic search of …

Objective The objective of this meta-analysis was to systematically assess the survival
benefit of aspirin use before or after diagnosis for patients with colorectal cancer (CRC) …

Background: The preventive role of non-steroid anti-inflammatory drugs (NSAIDs) and
aspirin, in particular, on colorectal cancer is well established. More recently, it has been …

Over 600,000 people worldwide die of colorectal cancer (CRC) annually, highlighting the
importance of developing effective prevention strategies. Among proposed chemopreventive …

We conducted a prospective, observational study of aspirin and COX-2 inhibitor use and
survival in stage III colon cancer patients enrolled in an adjuvant chemotherapy trial. Among …

Regular use of aspirin reduces incidence and mortality of various cancers, including
colorectal cancer. Anticancer effect of aspirin represents one of the 'Provocative Questions' …